MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 13,651 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 2.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 512,985 shares of the company's stock after buying an additional 13,651 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned about 0.11% of GE HealthCare Technologies worth $40,106,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. increased its stake in shares of GE HealthCare Technologies by 29.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,233,603 shares of the company's stock valued at $209,624,000 after acquiring an additional 512,778 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in GE HealthCare Technologies by 0.5% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 30,597 shares of the company's stock valued at $2,392,000 after acquiring an additional 146 shares in the last quarter. Harbor Capital Advisors Inc. grew its position in GE HealthCare Technologies by 4.6% in the fourth quarter. Harbor Capital Advisors Inc. now owns 8,779 shares of the company's stock valued at $686,000 after acquiring an additional 383 shares in the last quarter. Czech National Bank boosted its stake in shares of GE HealthCare Technologies by 6.5% during the 4th quarter. Czech National Bank now owns 99,060 shares of the company's stock valued at $7,745,000 after buying an additional 6,034 shares during the last quarter. Finally, City State Bank boosted its stake in shares of GE HealthCare Technologies by 51.6% during the 4th quarter. City State Bank now owns 561 shares of the company's stock valued at $44,000 after buying an additional 191 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Up 0.3%

NASDAQ GEHC traded up $0.22 during trading on Friday, reaching $73.13. 3,308,976 shares of the company's stock were exchanged, compared to its average volume of 3,410,423. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm has a market capitalization of $33.49 billion, a PE ratio of 16.89, a P/E/G ratio of 3.19 and a beta of 1.21. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The company's fifty day simple moving average is $71.27 and its 200-day simple moving average is $80.21.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.10. The business had revenue of $4.78 billion during the quarter, compared to analyst estimates of $4.66 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm's revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.90 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 25th were paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date was Friday, April 25th. GE HealthCare Technologies's payout ratio is 2.95%.

GE HealthCare Technologies declared that its Board of Directors has approved a stock buyback program on Wednesday, April 30th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 3.1% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's leadership believes its stock is undervalued.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on GEHC. Citigroup reduced their price objective on GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a research note on Wednesday, April 30th. BTIG Research set a $95.00 target price on GE HealthCare Technologies and gave the company a "buy" rating in a research note on Monday, April 14th. Wells Fargo & Company lowered their price target on GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating on the stock in a report on Thursday, May 1st. Morgan Stanley lowered their target price on GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Finally, The Goldman Sachs Group lowered their target price on GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $88.27.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.